Valuation: CellaVision AB

Market Cap 3.94B 401M 349M 330M 300M 561M 38.39B 564M 1.52B 19.51B 1.51B 1.47B 62.45B P/E 2026 *
28.3x
P/E 2027 * 22.6x
Enterprise Value 3.75B 382M 332M 315M 286M 534M 36.56B 537M 1.45B 18.58B 1.43B 1.4B 59.48B EV / Sales 2026 *
4.84x
EV / Sales 2027 * 4.27x
Free-Float
81.06%
Yield 2026 *
1.67%
Yield 2027 * 1.9%
1 day+3.78%
3 months+3.78%
6 months-13.23%
Current year-16.80%
Current year 13.49
Extreme 13.49
17.3
1 year 13.49
Extreme 13.49
17.3
3 years 13.49
Extreme 13.49
25.9
5 years 13.49
Extreme 13.49
34.75
10 years 13.49
Extreme 13.49
41.48
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+3.78%-.--% - - 401M
+0.02%+6.23%+20.16%-26.67% 17.66B
-0.40%+5.10%-45.81%+53.22% 1.87B
-0.45%-1.18%-32.47%+20.91% 879M
-0.13%+0.27%+50.00%-1.02% 781M
-0.81%-7.51%-63.37%-85.48% 761M
+0.38%-3.11%-38.31%-51.02% 634M
-2.82%-5.37%-43.96%-55.89% 560M
-1.93%-0.75%-44.02%-38.59% 450M
-3.87%+11.24%+55.28%+73.04% 454M
Average -0.62%+2.98%-15.83%-12.39% 2.67B
Weighted average by Cap. -0.16%+6.19%+7.85%-19.40%

Financials

2026 *2027 *
Net sales 775M 78.94M 68.76M 65.07M 59.13M 110M 7.56B 111M 300M 3.84B 297M 290M 12.3B 870M 88.61M 77.18M 73.04M 66.36M 124M 8.49B 125M 336M 4.31B 333M 325M 13.81B
Net income 139M 14.16M 12.33M 11.67M 10.6M 19.81M 1.36B 19.91M 53.75M 689M 53.19M 52M 2.21B 174M 17.76M 15.47M 14.64M 13.3M 24.85M 1.7B 24.97M 67.43M 864M 66.72M 65.23M 2.77B
Net Debt -188M -19.1M -16.63M -15.74M -14.3M -26.72M -1.83B -26.85M -72.5M -929M -71.74M -70.14M -2.98B -222M -22.6M -19.68M -18.63M -16.93M -31.62M -2.16B -31.78M -85.8M -1.1B -84.89M -83.01M -3.52B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
165.00SEK
Average target price
175.67SEK
Spread / Average Target
+6.46%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!